Pulmonary artery compliance in different forms of pulmonary hypertension

被引:10
作者
McCormick, Amber [1 ]
Krishnan, Amita [1 ]
Badesch, David [2 ]
Benza, Raymond L. [3 ]
Bull, Todd M. [2 ]
De Marco, Teresa [4 ]
Feldman, Jeremy [5 ]
Hemnes, Anna R. [6 ]
Hirsch, Russel [7 ]
Horn, Evelyn [8 ]
Kennedy, Jaime [9 ]
Mathai, Stephen C. [10 ]
McConnell, Wesley [11 ]
Pugliese, Steven C. [12 ]
Sager, Jeffrey S. [13 ]
Shlobin, Oksana A. [14 ]
Simon, Marc A. [4 ]
Lammi, Matthew R. [1 ]
机构
[1] Louisiana State Univ, Comprehens Pulm Hypertens Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA
[2] Univ Colorado Anschutz Med Campus, Div Pulm Sci & Crit Care Med, Denver, CO USA
[3] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Div Cardiovasc Med, Columbus, OH USA
[4] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA
[5] Arizona Pulm Specialists, Phoenix, AZ USA
[6] Vanderbilt Univ, Allergy Pulm & Crit Care Med, Nashville, TN USA
[7] Cincinnati Childrens Hosp Med Ctr, Heart Inst, Cincinnati, OH USA
[8] Weill Cornell Med Coll, Div Cardiol, New York, NY USA
[9] Inova Heart & Vasc Inst, Falls Church, VA USA
[10] Johns Hopkins Univ, Pulm & Crit Care Med, Baltimore, MD USA
[11] Kentuckiana Pulm Associates, Louisville, KY USA
[12] Univ Penn, Pulm Allergy & Crit Care, Philadelphia, PA USA
[13] Cottage Pulm Hypertens Ctr, Santa Barbara, CA USA
[14] Inova Fairfax Hosp, Adv Lung Disesae & Transplant Program, Falls Church, VA USA
关键词
Pulmonary Arterial Hypertension; Pulmonary Embolism; RIGHT-VENTRICULAR AFTERLOAD; SYSTEMIC-SCLEROSIS; VASCULAR-RESISTANCE; TIME CONSTANT; CAPACITANCE; MANAGEMENT; SURVIVAL; THERAPY;
D O I
10.1136/heartjnl-2022-321760
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Pulmonary artery compliance (PAC), estimated as stroke volume (SV) divided by pulmonary artery pulse pressure (PP), may be a predictor of survival in pulmonary arterial hypertension (PAH). Resistance- compliance (RC) time, the product of PAC and pulmonary vascular resistance, is reported to be a physiological constant. We investigated if differences in PAC and RC time exist between pulmonary hypertension (PH) subgroups and examined whether PAC is an independent predictor of transplant- free survival in PAH.Methods This was a retrospective analysis of adult PAH (n=532) and chronic thromboembolic PH (CTEPH, n=84) patients enrolled in the US Pulmonary Hypertension Association Registry from 2015 to 2019. PAC and RC time were compared between PH subgroups (connective tissue disease-PAH (CTD-PAH), idiopathic/heritable-PAH (i/h- PAH), drug/toxin- PAH (d/t-PAH)). Cox proportional hazards models were constructed for transplant- free survival, adjusting for REVEAL 2.0 risk score.Results There were no differences in estimated PAC between PAH subgroups, nor between PAH and CTEPH. RC time was shorter in CTEPH compared with PAH (median 0.55 (IQR 0.45-0.64) vs 0.62 (0.52-0.73) s, p < 0.0001). RC time was shortest in CTD- PAH when compared with i/h- PAH and d/t- PAH ((0.59 +/- 0.18) vs (0.65 +/- 0.20) vs (0.73 +/- 0.25) s, p=0.0001). PAC was associated with transplant- free survival (HR 0.72, 95% CI 0.55 to 0.94, p=0.02) but was not an independent predictor of outcome after adjustment for REVEAL 2.0 score.Conclusion PAC was similar between PH groups and was not an independent predictor of transplant- free survival in PAH. RC time was different between PH subgroups, challenging RC time constancy.
引用
收藏
页码:1098 / 1105
页数:8
相关论文
共 50 条
  • [41] Leukotriene B4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension
    Qian, Jin
    Tian, Wen
    Jiang, Xinguo
    Tamosiuniene, Rasa
    Sung, Yon K.
    Shuffle, Eric M.
    Tu, Allen B.
    Valenzuela, Antonia
    Jiang, Shirley
    Zamanian, Roham T.
    Fiorentino, David F.
    Voelkel, Norbert F.
    Peters-Golden, Marc
    Stenmark, Kurt R.
    Chung, Lorinda
    Rabinovitch, Marlene
    Nicolls, Mark R.
    HYPERTENSION, 2015, 66 (06) : 1227 - 1239
  • [42] Pulmonary Hypertension Care Center Network Improving Care and Outcomes in Pulmonary Hypertension
    Sahay, Sandeep
    Melendres-Groves, Lana
    Pawar, Leena
    Cajigas, Hector R.
    CHEST, 2017, 151 (04) : 749 - 754
  • [43] Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR)
    Garry, Jonah D.
    Kolaitis, Nicholas A.
    Kronmal, Richard
    Thenappan, Thenappan
    Hemnes, Anna
    Grinnan, Daniel
    Bull, Todd
    Chakinala, Murali M.
    Horn, Evelyn
    Simon, Marc A.
    De Marco, Teresa
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (12) : 1808 - 1818
  • [44] Comprehensive assessments of pulmonary circulation in children with pulmonary hypertension associated with congenital heart disease
    Muneuchi, Jun
    Ezaki, Hiroki
    Sugitani, Yuichiro
    Watanabe, Mamie
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [45] Serotonin hypothesis and pulmonary artery hypertension
    Kloza, Monika
    Baranowska-Kuczko, Marta
    Pedzinska-Betiuk, Anna
    Jackowski, Konrad
    Kozlowska, Hanna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2014, 68 : 738 - 748
  • [46] Pharmacologic therapy for pulmonary artery hypertension
    Nair, Ajith
    CURRENT OPINION IN CARDIOLOGY, 2020, 35 (06) : 643 - 656
  • [47] Iatrogenic pulmonary artery hypertension.
    Weitzenblum, E
    Kessler, R
    Chaouat, A
    REVUE DES MALADIES RESPIRATOIRES, 1996, 13 (02) : 133 - 139
  • [48] Pulmonary arterial compliance and exercise capacity after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
    Sermet, Romain
    Piliero, Nicolas
    Guillien, Alicia
    Madoun, Simon
    Doutreleau, Stephane
    Salvat, Muriel
    Finas, Mathieu
    Thony, Frederic
    Vautrin, Estelle
    Bouvaist, Helene
    Degano, Bruno
    ERJ OPEN RESEARCH, 2023, 9 (02)
  • [49] Pericardial effusion is correlated with clinical outcome after pulmonary artery denervation for pulmonary arterial hypertension
    Chen, Shao-Liang
    Zhang, Hang
    Xie, Du-Jiang
    Zhang, Juan
    Zhou, Ling
    Chen, Meng-Xuan
    Stone, Gregg W.
    ONCOTARGET, 2017, 8 (33) : 54106 - 54114
  • [50] Right Ventricular Dyssynchrony in Patients With Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
    Yamagata, Yuki
    Ikeda, Satoshi
    Kojima, Sanae
    Ueno, Yuki
    Nakata, Tomoo
    Koga, Seiji
    Ohno, Chikara
    Yonekura, Tsuyoshi
    Yoshimuta, Tsuyoshi
    Minami, Takako
    Kawano, Hiroaki
    Maemura, Koji
    CIRCULATION JOURNAL, 2022, 86 (06) : 936 - +